Hepatitis B Birth Dose Coverage among Infants in Plateau State, Nigeria

Authors

Nwosu Simon Onyekachi

Pre-eminent Empowerment and Development Foundation (Nigeria)

Article Information

DOI: 10.51244/IJRSI.2025.120800146

Subject Category: Public Health

Volume/Issue: 12/8 | Page No: 1652-1666

Publication Timeline

Submitted: 2025-08-24

Accepted: 2025-09-02

Published: 2025-09-15

Abstract

Hepatitis B virus (HBV) infection remains a significant public health challenge in Nigeria, with vertical (mother-to-child) transmission being a major route of infection. The World Health Organization (WHO) recommends administering the hepatitis B birth dose (HepB-BD) within 24 hours of birth to prevent perinatal transmission. However, the level of HepB-BD coverage across different regions of Nigeria remains suboptimal and poorly documented. This study assesses the coverage of the hepatitis B birth dose among infants in Plateau State, Nigeria, and identifies the determinants influencing vaccine uptake. Using a cross-sectional study design, data were collected through structured interviews with caregivers and health workers, as well as reviews of immunization records from selected health facilities across urban and rural areas of the state. The study evaluated birth dose administration rates, timing, and associated factors such as maternal education, place of delivery, awareness of HBV, availability of vaccines, and health system challenges. Preliminary findings reveal a low overall coverage of HepB-BD, with significant disparities between urban and rural communities, and a high proportion of infants receiving the vaccine beyond the recommended 24-hour window. Key barriers identified include inadequate maternal awareness, high rates of home deliveries, poor vaccine logistics, and health worker shortages. The study underscores the need for targeted health education, improved delivery and immunization services, and policy interventions to enhance timely administration of the birth dose. Strengthening the integration of maternal and child health services with immunization programs is critical for reducing HBV transmission and achieving national and global hepatitis elimination targets.

Keywords

Hepatitis B, HBV transmission, infants, immunization, HepB-BD, vaccine, liver

Downloads

References

1. National Institute of Diabetes and digestive and kidney diseases(U.S) Hepatitis B https://www.niddk.nih.gov/health-information/liver-disease/viral-hepatitis/hepatitis-b. 2020 [Google Scholar] [Crossref]

2. Centers for Disease control and prevention (CDC)(US) hepatitis B. https://www.cdc.gov/hepatitis/hbv/index.htm) 1/12/2024 [Google Scholar] [Crossref]

3. WHO, Preventing perinatal Hepatitis B virus transmission: A guide for introducing and strengthening Hepatitis B birth dose vaccination. [Google Scholar] [Crossref]

4. WHO, Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection, March, 2024. [Google Scholar] [Crossref]

5. FMOH, National Guidelines for prevention, care and treatment of Viral Hepatitis B and C in Nigeria. 2016. [Google Scholar] [Crossref]

6. Catherine Freeland et al: Barriers and facilitators to hepatitis B birth dose vaccination: perspectives from healthcare providers and pregnant women accessing antenatal care in Nigeria. Plos Glob public Health, 2023. Doi:10.1371/journal.pgph.0001332 [Google Scholar] [Crossref]

7. T.Y Padma: Scaling up Hepatitis B birth dose vaccination will save lives, and livers, experts say. 2024 [Google Scholar] [Crossref]

8. WHO EMTCT, Global validation Advisory Committee: Global Guidance on creating a process for validation. Elimination of mother-to-child transmission of HIV, Syphilis and Hepatitis B virus. 2021. https://www.who.iut/publication/i/item/9789240039360 {Google scholar}. [Google Scholar] [Crossref]

9. Spearman CW, Afihene M, Ally R, Apica B, AWUKU Y, Cunha L, et al. Hepatitis B in sub-sahara Africa: Strategies to achieve the 2030 elimination targets. Lancet Gastroenterology Hepatol.2017 (doi: 10:1016/S2468-1253 (17)30295-9) (Google scholar). [Google Scholar] [Crossref]

10. Ozele Kingsley Chukwuka. Mother- to-Child Transmission of Hepatitis B in Jos metropolis: Article 020122011 Greener journals. [Google Scholar] [Crossref]

11. Yusuf Musa et al. Liver cell cancer surveillance practice in Nigeria: pitfalls and future prospects. (World J Hepatol, 2024 [Google Scholar] [Crossref]

12. Yahaya Mohammed et al. Exploring the landscape of routine immunization in Nigeria: A scoping review of barriers and facilitators. National library of medicine. vaccine X. 2024 [Google Scholar] [Crossref]

13. Babayemi Oluwaseun Olakunde et al. Hepatitis B vaccine birth dose coverage among hepatitis B –exposed: and Hepatitis B unexposed infants. Pan African medical journal 14 Feb, 2024. [Google Scholar] [Crossref]

14. F.O Bada, Factors associated with receipt of a timely infant birth dose of Hepatitis B vaccine at a tertiary hospital in North-Central Nigeria- National library of medicine 12:2(9); e 0001052. Doi: 10.1371/journal.pgph.0001052 [Google Scholar] [Crossref]

15. Abov Ba MD et al. Journal of pediatrics, perinatology and Child Health. ISSN: 2641-7405. 2023. [Google Scholar] [Crossref]

16. WHO, Hepatitis B (https://www.who.int/news-room/fact-sheets/detail/hepatitis B. 2024 [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles